Abstract 5152: SJP1604, a nucleolin-targeted therapeutic agent for relapsed/refractory acute myeloid leukemia

Mapping Intimacies ◽

10.1158/1538-7445.am2020-5152 ◽

2020 ◽

Author(s):

Jihyun Um ◽

Dohyeong Lee ◽

Yongbin Park ◽

Sung Hwan Moon ◽

Soo Jin Lee ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Therapeutic Agent ◽

Refractory Acute Myeloid Leukemia ◽

Acute Myeloid ◽

Targeted Therapeutic

Download Full-text

Abstract 1430:In vivoPoC study and design for Phase I clinical study of SJP1604, a nucleolin-targeted therapeutic agent to treat entire population of relapsed/refractory acute myeloid leukemia patients

10.1158/1538-7445.am2021-1430 ◽

2021 ◽

Author(s):

Jihyun Um ◽

Dohyeong Lee ◽

So Hee Kim ◽

Eun-Hye Huh ◽

Yongbin Park ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Clinical Study ◽

Phase I ◽

Myeloid Leukemia ◽

Therapeutic Agent ◽

Entire Population ◽

Refractory Acute Myeloid Leukemia ◽

Acute Myeloid ◽

Targeted Therapeutic

Download Full-text

Abstract 344: SJP1604, a novel targeted therapeutic agent for AML (acute myeloid leukemia) including standard therapy-resistant AML

10.1158/1538-7445.sabcs18-344 ◽

2019 ◽

Author(s):

Jihyun Um ◽

Dohyeong Lee ◽

Jisun Oh ◽

Yongbin Park ◽

Sung Hwan Moon ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Standard Therapy ◽

Myeloid Leukemia ◽

Therapeutic Agent ◽

Acute Myeloid ◽

Targeted Therapeutic

Download Full-text

Abstract 344: SJP1604, a novel targeted therapeutic agent for AML (acute myeloid leukemia) including standard therapy-resistant AML

10.1158/1538-7445.am2019-344 ◽

2019 ◽

Author(s):

Jihyun Um ◽

Dohyeong Lee ◽

Jisun Oh ◽

Yongbin Park ◽

Sung Hwan Moon ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Standard Therapy ◽

Myeloid Leukemia ◽

Therapeutic Agent ◽

Acute Myeloid ◽

Targeted Therapeutic

Download Full-text

13 / MEK Inhibitor Binimetinib (MEK162) in Relapse and Refractory Acute Myeloid Leukemia: Results of a Phase I/II Study.

10.26226/morressier.5b3b802cb1b87b000eced984 ◽

2018 ◽

Author(s):

Maiti Abhishek

Keyword(s):

Acute Myeloid Leukemia ◽

Phase I ◽

Myeloid Leukemia ◽

Mek Inhibitor ◽

Refractory Acute Myeloid Leukemia ◽

Download Full-text

A Study of Gilteritinib (ASP2215) Combined With Chemotherapy in Children, Adolescents and Young Adults With FMS-like Tyrosine Kinase 3 (FLT3)/Internal Tandem Duplication (ITD) Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)

Case Medical Research ◽

10.31525/ct1-nct04240002 ◽

2020 ◽

Author(s):

Keyword(s):

Acute Myeloid Leukemia ◽

Young Adults ◽

Tyrosine Kinase ◽

Myeloid Leukemia ◽

Tandem Duplication ◽

Adolescents And Young Adults ◽

Internal Tandem Duplication ◽

Refractory Acute Myeloid Leukemia ◽

Flt3 Internal Tandem Duplication ◽

Download Full-text

Talazoparib and Gemtuzumab Ozogamicin for the Treatment of CD33 Positive Relapsed or Refractory Acute Myeloid Leukemia

Case Medical Research ◽

10.31525/ct1-nct04207190 ◽

2019 ◽

Author(s):

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Gemtuzumab Ozogamicin ◽

Refractory Acute Myeloid Leukemia ◽

Download Full-text

Sequential Azacitidine and Lenalidomide for Patients with Relapsed and Refractory Acute Myeloid Leukemia: Clinical Results and Predictive Modeling Using Computational Analysis

SSRN Electronic Journal ◽

10.2139/ssrn.3307702 ◽

2018 ◽

Author(s):

Brett Stevens ◽

Amanda Winters ◽

Jonathan A. Gutman ◽

Aaron Fullerton ◽

Gregory Hemenway ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Predictive Modeling ◽

Myeloid Leukemia ◽

Computational Analysis ◽

Clinical Results ◽

Refractory Acute Myeloid Leukemia ◽

Download Full-text

Pooled Clinical Safety Analysis of CPX-351 Versus Conventional Chemotherapy in Patients with Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2019.07.084 ◽

2019 ◽

Vol 19 ◽

pp. S214-S215

Author(s):

Jorge E. Cortes ◽

Robert J. Ryan ◽

Michael Chiarella

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Safety Analysis ◽

Newly Diagnosed ◽

Conventional Chemotherapy ◽

Clinical Safety ◽

Refractory Acute Myeloid Leukemia ◽

Download Full-text

Propensity-score Matched Comparison of Salvage Chemotherapy Regimens in Relapsed/Refractory Acute Myeloid Leukemia

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2021.01.011 ◽

2021 ◽

Author(s):

Justin H. Reid ◽

Bernard L. Marini ◽

Lydia L. Benitez ◽

Kristen Pettit ◽

Dale L. Bixby ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Propensity Score ◽

Myeloid Leukemia ◽

Salvage Chemotherapy ◽

Refractory Acute Myeloid Leukemia ◽

Matched Comparison ◽

Download Full-text

Acquired BCR-ABL1 fusion and IDH1 clonal evolution following BCL2 inhibitor treatment in refractory acute myeloid leukemia

Leukemia Research ◽

10.1016/j.leukres.2020.106494 ◽

2021 ◽

Vol 100 ◽

pp. 106494

Author(s):

Diego Adrianzen-Herrera ◽

Ximena Jordan-Bruno ◽

Katherine A. Devitt ◽

Joanna L. Conant ◽

Juli-Anne Gardner

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Clonal Evolution ◽

Refractory Acute Myeloid Leukemia ◽

Inhibitor Treatment ◽

Download Full-text